CD40 and pancreatic neoplasm: As summarized in Table 1, T-cell infiltrations in the pancreatic tumors treated with LIFE Biomaterial_anti-CD40 alone or combined with CONV_5 Gy, CONV_10 Gy, CONV_20 Gy, or Flash_5 Gy alone, respectively, have shown higher permeations of CD11b or CD3, CD4, and CD8 T-cells in the tumor microenvironment.